FYI the point of the blurry images is that the french have

New Post Public Reply Private Reply Replies (0) Message Board
joey68
FYI the point of the blurry images is that the french have suppliers for the wavSTAT which is being talked about in England. On top of this, the suppliers are located at the PENTAX facility in france. In addition, the MORDIS study has an approximate end date of November 2016. Its December right now. Could this mean the MORDIS study is complete? Could this be why SCIE is attending medtech 2017 in only 13 DAYS from now where some of the biggest investors in the country will match up with medical companies such as SCIE?

Why did SCIE find it important to buy oncoscopes technology? The technology itself is worth millions of dollars. What is going on behind the scenes right now? Why has SCIE told us on five separate occasions they have a SECOND device. Why does the wavstat show up on PENTAX's websites?

..see my point? Lots of stuff going on right now. This is one of those stocks where one day it could open at .006 and climb to .30 cents in a week. My opinion, but i stand by it. SCIE used to have sales of hundreds of thousands of dollars. It stopped because they couldnt keep up with demand, lost focus, had to reorganize, lost a year and a half trying to get back on track in england, then had to get the help of Jagworldwide. All of this is 100% verifiable DD found in my older posts. One of my posts has a video of the CEO admitting they messed up trying to sell the wavstat to england on their own; which cost them a year and a half of time. i dont make this stuff up.

So that people dont think im a pumper... could SCIE fail? sure it could. SCIE doesnt 'have to' succeed. They could go under. Will they? first off.. why would they? theres a huge need for better cancer detection. the UK has a pandemic of colon cancer; so does europe. SCIE has so many patents which were created by the smartest inventors/engineers in the industry.

At any time PENTAX could take the wavstat off of their webpages; but they dont. There must be a reason why they keep it up. I believe its showing because they know sales are coming.

All my opinion. Not investment advice. Seriously, do NOT invest based on this or any posts. Do your own DD.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Educational Play Mat Encourages Learning & Play

Updated Category News Views 135

Introducing the PALMER INVENTION: A Unique Educational Tool Creating an engaging and educational environment for children is essential for their development. An innovative inventor has crafted a solution that blends fun with learning through an exciting new play mat. This inventive approach caters to the foundational skills of spelling, reading, and numerical...

Continue Reading
Huajiang Grand Canyon Bridge: A Testament to China's Innovation

Updated Category News Views 282

The Huajiang Grand Canyon Bridge: A New Era of Engineering Recently, a remarkable engineering project, the Huajiang Grand Canyon Bridge, was completed and opened to traffic. This bridge not only boasts the title of the world’s tallest bridge but also serves as a vital part of the Liuzhi-Anlong Expressway in a mountainous region of China. What makes this bridge...

Continue Reading
Paragon 28's Strategic Moves in Leadership and Innovation

Updated Category News Views 182

Executive Transition at Paragon 28 Paragon 28, Inc., a prominent name in surgical and medical instruments, has recently made headlines with Erik Mickelson's announcement of his departure from the role of Chief Accounting Officer. This decision reflects the company’s commitment to transparency, confirming that his leaving is not tied to any disputes or financial...

Continue Reading
Understanding Plumbing Design and Infection Control Risks

Updated Category News Views 313

Join the Upcoming Webinar on Plumbing Design Chicago Faucets is hosting an informative webinar with plumbing expert Brian Yelton where he will dive into the crucial aspects of plumbing design and how it relates to waterborne infection risks within buildings. Understanding these elements is essential for architects, engineers, and facility managers. With the ongoing focus...

Continue Reading
Caribou Biosciences Under Investigation: What Investors Should Know

Updated Category News Views 261

Overview of Caribou Biosciences' Situation Caribou Biosciences, Inc. is currently under scrutiny due to a class action complaint filed on behalf of long-term stockholders. The focus of this investigation is centered around potential breaches of fiduciary duties by the company's board of directors. The complaint raises concerns about the accuracy of statements made...

Continue Reading